Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGT003 for peripheral arterial bypass grafts
NCT00041925Phase 3Completed
- Sponsor
- Anesiva
- Start
- Nov 2001
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 2
01
Overview
A Phase 3 trial of edifoligide in Graft failure, Graft Stenosis, sponsored by Anesiva. Started Nov 2001; status: completed.
02
Drugs
edifoligide
03
Conditions
Graft failureGraft Stenosis
Beyond the preview
Go deeper on NCT00041925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041925.